Stem Cell Therapy International, Inc Treats Multiple Sclerosis
Related News: Stem Cell ResearchStem Cell Therapy International, Inc. (OTC: SCII),is reporting today that they have had successful results from stem cell transplantation therapy that was performed last November on a 42-year-old man. The man was diagnosed with progressive multiple sclerosis (MS) three years ago.
Shop owner Samuel Bonnar, from Newtownabbey, Ireland, was experiencing debilitation that included difficulty speaking and poor circulation. He was walking with crutches and was able to climb stairs only by lifting his left leg with each step. Traditional treatment for MS at two different hospitals in Ireland resulted in little to no effect.
SCTI arranged for Mr. Bonnar to be treated with injections of a stem cell biological solution at the SCTI affiliate medical facility in Kiev, Ukraine on November 27th, 2005.
"The positive results of the therapy were remarkable and almost instant," Calvin Cao, CEO of Stem Cell Therapy International (SCTI) reported. "Within a few days, Mr. Bonnar's speech and mobility were vastly improved and after two weeks he had regained the ability to climb a full set of stairs without having to lift his left leg with his hand. Numbness in the fingertips of both hands subsided and occurs now only occasionally."
Read the entire press release at Stem Cell Therapy International Reports Successful Treatment of Multiple Sclerosis Patient With Stem Cell Transplantation Therapy
Watch Mr. Bonnar's stem cell therapy video interview
Posted on February 28, 2006 07:25 PM